日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

Micronuclei: origins, assays, mechanisms, diseases and treatments

微核:起源、检测方法、机制、疾病和治疗

Duan, Hailong; Peng, Xin; Qin, Sha; Zhou, Yanmin; Xiao, Desheng; Tao, Yongguang; Liu, Shuang

Visinin-like protein 1 disrupts calcium homeostasis and promotes atrial fibrillation in human and rodent models

视蛋白样蛋白1破坏钙稳态,并在人类和啮齿动物模型中促进心房颤动。

Xiong, Ke; Wang, Guanghua; Li, Desheng; Shao, Beihua; Chen, Zhiwen; Zou, Qicheng; Zhang, Xinrui; Dong, Yanru; Zhao, Xuxia; Yuan, Yixin; Xu, Hongtao; Liu, Yi; Liang, Dandan; Wang, Li; Zhou, Bin; Dong, Nianguo; Xie, Duanyang; Chen, Yi-Han

Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study

抗PD-1抗体penpulimab联合化疗治疗复发性或转移性鼻咽癌:一项随机、双盲3期研究

Huang, Shuang; Liu, Feng; Qu, Song; Chen, Lisha; Zhou, Ping; Qu, Shenhong; Ai, Xiaohong; Chen, Yong; Liu, Meilian; Wang, Rensheng; Chan, Kelvin Kw; Zhang, Peng; Hu, Chunhong; Wen, Jiyu; Zhang, Jian; Lin, Qin; Li, Xiaojiang; Gu, Kangsheng; Xiang, Li; Wang, Dongxia; Li, Jingao; Lin, Daren; Hu, Desheng; Ding, Jianwu; Wang, Siyang; Huang, Xiaoming; Wang, Lin; Jin, Feng; Pfister, David G; Mak, Milena Perez; Marchi, Pedro Rafael Martins de; Jiang, Yi; Yang, Haihua; Hu, Xiaoye; Liu, Tianrun; Wu, Dehua; Shreenivas, Aditya; Oliveira, Thiago Bueno de; Silva, Carlos Eduardo Baston; Alves, Gustavo Vasconcelos; Li, Xianming; Yao, Zhifang; Lu, Dongmei; Hu, Mingxiu; Wang, Zhongmin Maxwell; Li, Baiyong; Xia, Michelle; Chen, Xiaozhong; Hu, Chaosu; Xu, Tingting

Biomimetic Gradient Lubrication Hydrogel Contrived by Self-Reinforced MOFs Nanoparticle Network

基于自增强型金属有机框架纳米颗粒网络的仿生梯度润滑水凝胶

Liu, Desheng; Wang, Yixian; Bai, Changcheng; Hu, Danli; Yang, Xingxing; Lu, Yaozhong; Wu, Tao; Zhai, Fei; Jiang, Pan; Wang, Xiaolong; Liu, Weimin

DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid Nanoparticles

通过靶向siRNA-脂质纳米颗粒增强胰腺神经内分泌肿瘤治疗的DNA修复酶调控策略

Wang, Fei; Li, Yan; Xu, Junfeng; Tang, Wei; Xu, Xiaowu; Lou, Xin; Jing, Desheng; Fan, Guixiong; Qin, Yi; Chen, Jie; Yu, Xianjun; Cai, Weibo; Tang, Zhongmin; Ji, Shunrong

Precise excision of expanded GGC repeats in NOTCH2NLC via CRISPR/Cas9 for treating neuronal intranuclear inclusion disease.

利用 CRISPR/Cas9 技术精确切除 NOTCH2NLC 中扩增的 GGC 重复序列,用于治疗神经元核内包涵体病。

Xie Nina, Pan Yongcheng, Tong Huichun, Lin Yingqi, Jiang Ying, Wang Zhiqin, Wan Juan, Zhang Wendiao, Wang Xinhui, Sun Xiaobo, Yan Sen, Yin Peng, Sun Qiying, Qi Chengzhi, Tian Yun, Shen Lu, Jiang Hong, Liang Desheng, Tang Beisha, Li Shihua, Li Xiao-Jiang, Liu Qiong

Artificial intelligence-enabled ultrasound diagnosis and stratification of follicular thyroid neoplasms: a multi-center study

人工智能辅助超声诊断和滤泡性甲状腺肿瘤分层:一项多中心研究

Li, Jianming; Zhang, Haoyan; Zheng, Huan; Cang, Yuancheng; Qian, Lin Xue; Cui, Ligang; Wu, Xinping; Chen, Baoding; Lu, Man; Xu, Yong; Miao, Runqin; Sun, Desheng; Liu, Liping; Li, Ping; Xu, Changsong; Ma, Li; Hua, Guoyong; Huo, Shengnan; Liu, Yanjun; Dai, Weide; Lou, Kexin; Xie, Xiang; Yang, Liping; Mei, Fang; Ping, Bo; Yang, Xin; Yu, Jie; Wang, Kun; Liang, Ping

Safety and Efficacy of Lucitanib Plus Toripalimab in Advanced Solid Tumors Refractory to Standard Therapies: An Open-Label, Multicenter, Phase II Study

Lucitanib联合Toripalimab治疗对标准疗法耐药的晚期实体瘤的安全性和有效性:一项开放标签、多中心、II期研究

Zhou, Ting; Sun, Haishuang; Chen, Gang; Zhang, Guoping; Wu, Jinsheng; Qu, Shenhong; Han, Yaqian; Hu, Desheng; Ling, Yang; Zheng, Yulong; Liu, Jian; Lin, Lizhu; Li, Yongsheng; Pan, Jianji; Liu, Yanyan; Wang, Cuiying; Fu, Guohong; Feng, Jian; Shi, Jianhua; Cai, Huiming; Li, Meng; Li, Fugen; Wang, Yinbin; Zhang, Li; Yang, Yunpeng

Anti-LAG-3 Antibody LBL-007 plus Tislelizumab and Chemotherapy as First-Line Therapy for Advanced Nasopharyngeal Carcinoma: A Multicenter Phase 2 Trial

抗LAG-3抗体LBL-007联合替雷利珠单抗和化疗作为晚期鼻咽癌一线治疗:一项多中心II期试验

Sun, Dongchen; Chen, Gang; Chen, Yu; Qu, Song; Liu, Lei; Yang, Kunyu; Li, Jingao; Chen, Lisha; Huang, Xiaoming; Zhu, Haisheng; Tang, Wenjun; Wang, Rensheng; Han, Yaqian; Hu, Desheng; Gao, Jin; Chen, Xiaozhong; Xiong, Hailin; Chen, Wu; Fan, Bin; Cai, Shengli; Kang, Xiaoqiang; Zhang, Li; Yang, Yunpeng